"/> Novus Biologicals™ Peptide bloquant d’anticorps IL… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps IL-21R

Réf. : BL-RE-082494Réf. fabricant : 18298095 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
50615
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-76739. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 15 amino acids near the extracellular domain of human IL-21 Receptor.

Points forts

Source

Synthetic

(Accession #: NP_068570) The IL-21R Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-082494
Réf. fabricant18298095
Gene ID (Entrez)50615
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-76739. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneCD360 antigen, IL-21 receptor, IL-21 R, interleukin 21 receptor, interleukin-21 receptor, MGC10967, NILR, Novel interleukin receptor
Symbole de gène(s)IL21R
Type de produitIL-21 R
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne15 amino acids near the extracellular domain of human IL-21 Receptor
Une question, une configuration particulière ?
Contactez-nous pour un devis.